Brief: Ryvu Therapeutics Allots 4.8 Mln J Series Shares
Dec 22 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* ALLOTS 4.8 MILLION J SERIES SHARES
* REDUCTION RATE FOR INDIVIDUAL INVESTORS AT 55.51%
* TOTAL ISSUE VALUE AT 250.3 MILLION ZLOTYS
Source text for Eikon: ID:nEM3zyCtWa
Further company coverage: RVU.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys